0000000000749617

AUTHOR

L. Raffaele

showing 3 related works from this author

Use of 70 MeV proton beam for medical applications at INFN-LNS: CATANA project

2000

The project CATANA (Centro di Adro Terapia ed Applicazioni Nucleari Avanzate) is a collaboration between the INFN-Laboratori Nazionali del Sud (LNS), Physics Department, Ophthalmology Institute and Radiology Institute of the Catania University and CSFNSM Catania. The main goal of CATANA is the study and the application of protontherapy for the treatment of shallow tumors (4 cm max) like uveal melanomas and subfoveal macular degenerations.

Proton computed tomographymedicine.medical_specialtybusiness.industryMedicinePatient treatmentMedical physicsbusinessNuclear medicineNeutron dosimetryAIP Conference Proceedings
researchProduct

Analisi di sicurezza nella procedura di protonterapia oculare applicata presso i Laboratori del Sud dell’INFN di Catania

2017

A partire dal 2002, l’Azienda Ospedaliera Universitaria “Policlinico Vittorio Emanuele” di Catania ha effettuato il trattamento di circa 350 pazienti affetti da neoplasie oculari mediante fasci di protoni prodotti con il ciclotrone disponibile presso i Laboratori nazionali del Sud (LNS). Tale impianto viene utilizzato per attività di ricerca nell’ambito della fisica sperimentale, per cui è stato necessario modificare le caratteristiche del fascio, rendendolo idoneo alle applicazioni cliniche. Il lavoro di ricerca ha riguardato lo svolgimento della analisi del rischio volto ad individuare possibili fallimenti nelle procedure adottate per il trattamento del paziente sottoposto a cicli di prot…

Settore ING-IND/20 - Misure E Strumentazione Nucleariprotonterapia Analisi di sicurezza Hierarchical Task Analysis Cognitive Task Analysis Human Error Assessment and Reduction TechniqueSettore ING-IND/19 - Impianti Nucleari
researchProduct

Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

2019

OBJECTIVE:\ud We estimated the cost consequence of Italian National Health System (NHS) investment in direct-acting antiviral (DAA) therapy according to hepatitis C virus (HCV) treatment access policies in Italy.\ud \ud METHODS:\ud A multistate, 20-year time horizon Markov model of HCV liver disease progression was developed. Fibrosis stage, age and genotype distributions were derived from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER) cohort. The treatment efficacy, disease progression probabilities and direct costs in each health state were obtained from the literature. The break-even point in time (BPT) was defined as the period of time required for the cumulativ…

Liver CirrhosisPediatricsTime FactorsSettore MED/09 - Medicina InternaNational Health ProgramsERADICATIONOUTBREAKantiviral treatment anti HCV economic consequencesHepacivirusLIVER FIBROSISSeverity of Illness IndexHealth Services AccessibilityCOST-EFFECTIVENESSIndirect costs0302 clinical medicineEpidemiologyvirus infection030212 general & internal medicinehealth care economics and organizationscost effectiveness030503 health policy & servicesHealth PolicyHealth services researchhealthHepatitis CHepatitis CMarkov Chainschronic hepatitis C virus infection fibrosis progression cost effectiveness liver fibrosisItalyPharmacology; Health Policy; Public Health Environmental and Occupational HealthCohortSettore SECS-P/03 - Scienza delle FinanzeDisease ProgressionPublic Health0305 other medical scienceViral hepatitisAnti-HCV antiviral treatmentCHRONIC HEPATITIS-Cmedicine.medical_specialtyGenotypeSettore MED/12 - GASTROENTEROLOGIAVIRUS-INFECTIONAntiviral AgentsNO03 medical and health sciencesCost SavingsAntiviral Agents; Cost Savings; Disease Progression; Genotype; Health Policy; Health Services Accessibility; Hepacivirus; Hepatitis C; Humans; Italy; Liver Cirrhosis; Markov Chains; National Health Programs; Severity of Illness Index; Time FactorsmedicineMANAGEMENTHumanschronic hepatitis CINDUCED DISEASESMETAANALYSISPharmacologyHealth economicsbusiness.industryPublic healthEnvironmental and Occupational HealthPublic Health Environmental and Occupational Healthmedicine.diseaseFIBROSIS PROGRESSIONbusiness
researchProduct